Us Congress House Bill HB1864

Us Congress 2025-2026 Regular Session

• Introduced: 3/5/25
• Refer: 3/5/25

Caption

Risky Research Review Act

Impact

If enacted, this legislation would significantly alter how federal funding is allocated for life sciences research. The Board would possess the authority to delay or deny funding based on evaluations of risk and potential consequences, thereby impacting ongoing and future research projects. Supporters argue that this will protect public health by ensuring that potentially dangerous research does not proceed without thorough scrutiny. However, there are concerns about how this could stifle innovative research that might benefit society.

Summary

House Bill 1864, titled the 'Risky Research Review Act,' proposes the establishment of the Life Sciences Research Security Board aimed at overseeing federal funding for life sciences research. This board will be responsible for reviewing any research classified as high-risk, particularly those involving high-consequence pathogens or gain-of-function studies. Its jurisdiction will ensure that funding allocations enhance public safety and health security while navigating the complex waters of scientific inquiry.

Contention

The bill also sparked contention regarding the scope and powers of the Board in determining what qualifies as high-risk research, with critics expressing fears that excessive regulation could hinder scientific progress. The requirement for ongoing disclosures by research entities about any changes in circumstances that could elevate the risk profile of a study is also debated. Proponents advocate for accountability and transparency, while opponents worry about the potential for overreach and bureaucratic obstacles that may be created in the name of safety.

Congress_id

119-HR-1864

Policy_area

Health

Introduced_date

2025-03-05